Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.

Stalder, Gregoire; Alberio, Lorenzo

Stalder, Gregoire; Alberio, Lorenzo.

Stalder G; Centre Hospitalier Universitaire Vaudois.
Alberio L; Centre Hospitalier Universitaire Vaudois.

Blood ; 136(7): 915, 2020 08 13.

Article in English | MEDLINE | ID: covidwho-714293

Subject(s)

Antiviral Agents/adverse effects; Coronavirus Infections/pathology; Eryptosis/drug effects; Erythrocytes/drug effects; Lopinavir/adverse effects; Pneumonia, Viral/pathology; Ritonavir/adverse effects; Aged, 80 and over; Antiviral Agents/administration & dosage; Betacoronavirus/drug effects; Betacoronavirus/immunology; Betacoronavirus/pathogenicity; COVID-19; Coronavirus Infections/diagnostic imaging; Coronavirus Infections/drug therapy; Coronavirus Infections/virology; Drug Combinations; Erythrocytes/pathology; Erythrocytes/virology; Humans; Lopinavir/administration & dosage; Lung/diagnostic imaging; Lung/pathology; Lung/virology; Male; Pandemics; Pneumonia, Viral/diagnostic imaging; Pneumonia, Viral/drug therapy; Pneumonia, Viral/virology; Ritonavir/administration & dosage; SARS-CoV-2; Tomography, X-Ray Computed

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Coronavirus Infections / Ritonavir / Erythrocytes / Lopinavir / Eryptosis Type of study: Case report Limits: Humans / Male Language: English Journal: Blood Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google